SEC Form 4 · accession 0001140361-18-010977
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Robert Baffi
Officer — EVP, Technical Operations
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 8:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F3,F2,F4 | Feb 26, 2018 | A | 12,190 | $0.00 | A | 81,084 | D | |
| Common StockF5 | holding | — | — | — | 77,055 | I | Shares held by Baffi Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.
- F2Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements.
- F3Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events.
- F4Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) exclude 55,663 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 4,526 shares inadvertently included in prior reports based on a reconciliation with the Company's records.
- F5Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) include 40,426 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) include 7,868 shares inadvertently excluded in prior reports based on a reconciliation with the Company's records.